Mastrapasqua Asset Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $18.5M | Sell |
36,626
-291
| -0.8% | -$155K | 2.17% | 10 |
|
|
2023
Q2 | $19.3M | Sell |
36,917
-374
| -1% | -$202K | 2.17% | 10 |
|
|
2023
Q1 | $21.5M | Buy |
37,291
+243
| +0.7% | +$137K | 2.64% | 4 |
|
|
2022
Q4 | $20.4M | Buy |
37,048
+186
| +0.5% | +$98.6K | 2.69% | 4 |
|
|
2022
Q3 | $18.7M | Sell |
36,862
-33
| -0.1% | -$18.5K | 2.71% | 4 |
|
|
2022
Q2 | $20M | Sell |
36,895
-425
| -1% | -$234K | 2.73% | 4 |
|
|
2022
Q1 | $22M | Sell |
37,320
-1,739
| -4% | -$999K | 2.47% | 6 |
|
|
2021
Q4 | $26.1M | Buy |
39,059
+202
| +0.5% | +$126K | 2.56% | 6 |
|
|
2021
Q3 | $22.2M | Sell |
38,857
-1,090
| -3% | -$598K | 2.43% | 7 |
|
|
2021
Q2 | $20.2M | Sell |
39,947
-278
| -0.7% | -$131K | 2.13% | 8 |
|
|
2021
Q1 | $18.4M | Buy |
40,225
+2,475
| +7% | +$1.18M | 2.15% | 7 |
|
|
2020
Q4 | $17.6M | Sell |
37,750
-1,073
| -3% | -$503K | 2.31% | 7 |
|
|
2020
Q3 | $17.1M | Buy |
38,823
+163
| +0.4% | +$67.3K | 2.4% | 7 |
|
|
2020
Q2 | $14M | Sell |
38,660
-75
| -0.2% | -$25.1K | 2.16% | 8 |
|
|
2020
Q1 | $11M | Buy |
38,735
+2,705
| +8% | +$853K | 2.13% | 9 |
|
|
2019
Q4 | $11.7M | Buy |
36,030
+325
| +0.9% | +$98.5K | 1.93% | 12 |
|
|
2019
Q3 | $10.4M | Sell |
35,705
-544
| -2% | -$156K | 1.91% | 13 |
|
|
2019
Q2 | $10.6M | Sell |
36,249
-1,328
| -4% | -$366K | 2.02% | 9 |
|
|
2019
Q1 | $10.3M | Buy |
37,577
+477
| +1% | +$119K | 1.95% | 8 |
|
|
2018
Q4 | $8.3M | Sell |
37,100
-1,003
| -3% | -$235K | 1.85% | 9 |
|
|
2018
Q3 | $9.3M | Buy |
38,103
+114
| +0.3% | +$26.2K | 1.76% | 12 |
|
|
2018
Q2 | $7.87M | Sell |
37,989
-281
| -0.7% | -$59.6K | 1.57% | 16 |
|
|
2018
Q1 | $7.9M | Buy |
38,270
+1,225
| +3% | +$257K | 1.61% | 16 |
|
|
2017
Q4 | $7.03M | Sell |
37,045
-1,476
| -4% | -$283K | 1.42% | 22 |
|
|
2017
Q3 | $7.29M | Buy |
38,521
+338
| +0.9% | +$61.2K | 1.5% | 21 |
|
|
2017
Q2 | $6.66M | Sell |
38,183
-873
| -2% | -$147K | 1.44% | 24 |
|
|
2017
Q1 | $6M | Buy |
39,056
+1,057
| +3% | +$162K | 1.34% | 26 |
|
|
2016
Q4 | $5.36M | Sell |
37,999
-270
| -0.7% | -$39.8K | 1.3% | 32 |
|
|
2016
Q3 | $6.09M | Sell |
38,269
-821
| -2% | -$127K | 1.5% | 24 |
|
|
2016
Q2 | $5.78M | Buy |
39,090
+715
| +2% | +$106K | 1.44% | 26 |
|
|
2016
Q1 | $5.43M | Sell |
38,375
-1,046
| -3% | -$140K | 1.27% | 34 |
|
|
2015
Q4 | $5.59M | Sell |
39,421
-470
| -1% | -$62.7K | 1.37% | 29 |
|
|
2015
Q3 | $4.88M | Buy |
39,891
+426
| +1% | +$55.5K | 1.29% | 32 |
|
|
2015
Q2 | $5.12M | Buy |
+39,465
| New | +$5.14M | 1.24% | 38 |
|
|
2015
Q1 | – | Sell |
-42,332
| Closed | -$5.3M | – | 115 |
|
|
2014
Q4 | $5.3M | Buy |
+42,332
| New | +$5.15M | 1.28% | 33 |
|
|
2014
Q2 | $5.69M | Buy |
48,214
+186
| +0.4% | +$21.9K | 1.31% | 34 |
|
|
2014
Q1 | $5.78M | Sell |
48,028
-2,594
| -5% | -$308K | 1.36% | 33 |
|
|
2013
Q4 | $5.64M | Buy |
50,622
+107
| +0.2% | +$10.6K | 1.28% | 32 |
|
|
2013
Q3 | $4.66M | Buy |
50,515
+1,484
| +3% | +$134K | 1.14% | 36 |
|
|
2013
Q2 | $4.15M | Buy |
+49,031
| New | +$4.08M | 1.1% | 41 |
|
Other funds holding TMO
Mastrapasqua Asset Management's TMO Position: Q3 2023 in Review
Mastrapasqua Asset Management reduced its Thermo Fisher Scientific (TMO) stake by 0.79% in Q3 2023, selling an estimated $155K and leaving 36,626 shares worth $18.5M. The position accounts for 2.17% of the portfolio, ranked #10.
Mastrapasqua Asset Management first reported a position in TMO in Q2 2013 and has held it in 40 quarters since. The position peaked at $26.1M in Q4 2021. 2,364 funds tracked by Wall St. Rank hold TMO as of Q3 2023.
- Mastrapasqua Asset Management held 36,626 shares of Thermo Fisher Scientific worth $18.5M as of Q3 2023.
- Mastrapasqua Asset Management sold 291 Thermo Fisher Scientific shares in Q3 2023, an estimated $155K.
- Thermo Fisher Scientific made up 2.17% of Mastrapasqua Asset Management's portfolio in Q3 2023, its #10 holding.
- Mastrapasqua Asset Management first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 40 quarters since.
- Mastrapasqua Asset Management's Thermo Fisher Scientific position peaked at $26.1M in Q4 2021.
- 2,364 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2023.
Based on Mastrapasqua Asset Management's 13F filing for Q3 2023, filed 25 Oct 2023.